Clinical trial
Asprosin as a Potential Biomarker for Disease Activity in Behcet Disease
NCT07803198 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Asprosin as a Potential Biomarker for Disease Activity in Behcet Disease
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- October 30, 2027
- Enrollment
- 44 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
behcet disease